Skip to main content
. 2018 Apr 30;8:6748. doi: 10.1038/s41598-018-25137-w

Figure 3.

Figure 3

EGFP-TARG1 localizes to transcriptionally active nucleoli independent of ADP-ribosylation. (a) Live cell imaging of U2OS cells transiently expressing EGFP-TARG1 or EGFP together with mCherry-H2B. Intensity profiles for EGFP and mCherry fluorescence signals are displayed that were measured along the arrows depicted in the merge pictures. DIC: differential interference contrast. (b) Live cell imaging of U2OS cells transiently expressing EGFP-TARG1 wildtype (WT), G43E, I44E or G123E together with mCherry-H2B. For intensity profiles, see Supplementary Figures S7. (c) U2OS cells transiently expressing EGFP-TARG1 or EGFP-TARG1-G123E together with mCherry-H2B were treated with 10 ng/ml actinomycin D (ActD) or DMSO for 90 min. Subcellular localization of EGFP-TARG1 (wildtype or G123E) was analyzed by confocal microscopy in living cells.